Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Skitzki

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
British Journal of Haematology|February 26, 2015
Entinostat, a novel histone deacetylase inhibitor is active in B-cell lymphoma and enhances the anti-tumour activity of rituximab and chemotherapy agentsSarah Frys, Zachary Simons, Qiang Hu, et al.
The Journal of Surgical Research|October 10, 2025
The Atypical Presentation and Delayed Timing of Anastomotic Leak in Patients Who Undergo Cytoreducation and Hyperthermic Intraperitoneal ChemotherapyColin J Rog, Riom Kwakman, Charlotte van Schooten, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
Efineptakin alfa (NT-I7) improves overall survival and induces tertiary lymphoid structures in murine lung tumorsTrang Dinh, Judong Lee, Sidra Islam, et al.
Gynecologic Oncology|November 21, 2022
Carboplatin enhances lymphocyte-endothelial interactions to promote CD8<sup>+</sup> T cell trafficking into the ovarian tumor microenvironmentJaron Mark, Dan T Fisher, Minhyung Kim, et al.
Molecular Therapy Oncolytics|May 20, 2022
Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of plasmid CXCL9 synergizes with plasmid IL-12 therapy to elicit robust anti-tumor immunityJack Y Lee, Bianca Nguyen, Anandaroop Mukhopadhyay, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2013
Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonistLyudmila G Burdelya, Craig M Brackett, Bojidar Kojouharov, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 9, 2019
Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in OncologyDaniel G Coit, John A Thompson, Mark R Albertini, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 7, 2016
NCCN Guidelines Insights: Melanoma, Version 3.2016Daniel G Coit, John A Thompson, Alain Algazi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 10, 2016
Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in OncologyDaniel G Coit, John A Thompson, Alain Algazi, et al.
Journal for Immunotherapy of Cancer|November 17, 2020
Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery CommitteeBrian Gastman, Piyush K Agarwal, Adam Berger, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
British Journal of Haematology|February 26, 2015
Entinostat, a novel histone deacetylase inhibitor is active in B-cell lymphoma and enhances the anti-tumour activity of rituximab and chemotherapy agentsSarah Frys, Zachary Simons, Qiang Hu, et al.
The Journal of Surgical Research|October 10, 2025
The Atypical Presentation and Delayed Timing of Anastomotic Leak in Patients Who Undergo Cytoreducation and Hyperthermic Intraperitoneal ChemotherapyColin J Rog, Riom Kwakman, Charlotte van Schooten, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
Efineptakin alfa (NT-I7) improves overall survival and induces tertiary lymphoid structures in murine lung tumorsTrang Dinh, Judong Lee, Sidra Islam, et al.
Gynecologic Oncology|November 21, 2022
Carboplatin enhances lymphocyte-endothelial interactions to promote CD8<sup>+</sup> T cell trafficking into the ovarian tumor microenvironmentJaron Mark, Dan T Fisher, Minhyung Kim, et al.
Molecular Therapy Oncolytics|May 20, 2022
Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of plasmid CXCL9 synergizes with plasmid IL-12 therapy to elicit robust anti-tumor immunityJack Y Lee, Bianca Nguyen, Anandaroop Mukhopadhyay, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2013
Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonistLyudmila G Burdelya, Craig M Brackett, Bojidar Kojouharov, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 9, 2019
Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in OncologyDaniel G Coit, John A Thompson, Mark R Albertini, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 7, 2016
NCCN Guidelines Insights: Melanoma, Version 3.2016Daniel G Coit, John A Thompson, Alain Algazi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 10, 2016
Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in OncologyDaniel G Coit, John A Thompson, Alain Algazi, et al.
Journal for Immunotherapy of Cancer|November 17, 2020
Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery CommitteeBrian Gastman, Piyush K Agarwal, Adam Berger, et al.
Pageof 4